John Somberg to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications John Somberg has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.130
-
First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials. Am J Ther. 2007 Nov-Dec; 14(6):594-604.
Score: 0.074
-
A case of herceptin cardiotoxicity. Am J Ther. 2004 Jan-Feb; 11(1):74-6.
Score: 0.057